Enter assignee name

EPO Patents = 1

Forward Citations = 8

Loading Chart...

7 inventors (with patents filed for the assignee):

Arthur Mertz Krieg (4 out of 68 patents)

Aaron Jay Morris (3 out of 4 patents)

Frank Hennecke (1 out of 2 patents)

4. George J Weiner (1 out of 13 patents)

5. Evan David Walters (1 out of 1 patent)

6. David Mauro (1 out of 1 patent)

7. Mohammed Milhem (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 12246031 - Compositions and methods for tumor immunotherapy (2025-03-11),

2. 12123003 - Synthetic RIG-I-like receptor agonists (2024-10-22),

3. 12084655 - Packaging oligonucleotides into virus-like particles (2024-09-10),

4. 10907161 - Synthetic RIG-I-like receptor agonists (2021-02-02),

5. 10682365 - Combination tumor immunotherapy (2020-06-16),

Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on discovering and developing novel immuno-oncology therapies for patients with cancer. The company’s lead product candidate, CM-24, is a monoclonal antibody that targets PD-1, currently undergoing clinical trials in various cancer types. With a commitment to advancing cancer treatment through innovative approaches, Checkmate aims to improve patient outcomes and quality of life. Their research focuses on harnessing the body’s immune system to fight tumors, offering hope for effective cancer therapies. The company is dedicated to scientific excellence, collaboration, and transparency in its mission to transform cancer treatment.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

5 Patents

#336 in Cambridge, MA

#2,815 in Massachusetts

#50,237 in US

Cambridge, MA, United States of America

Checkmate Pharmaceuticals, Inc.